Elliot L. Servais

Regional delivery of mesothelin-targeted CAR T cell therapy generates potent and long-lasting CD4-dependent tumor immunity

Prasad S. Adusumilli, Leonid Cherkassky, Jonathan Villena‐Vargas et al. · Science Translational Medicine · 2014 · 567 citations

Life Sciences, Immunology, Oncology +13

Outcome of Primary Tumor in Patients With Synchronous Stage IV Colorectal Cancer Receiving Combination Chemotherapy Without Surgery As Initial Treatment

George A. Poultsides, Elliot L. Servais, Leonard B. Saltz et al. · Journal of Clinical Oncology · 2009 · 390 citations · Full text

Medicine, Oncology, Surgery +17

Mesothelin Overexpression Promotes Mesothelioma Cell Invasion and MMP-9 Secretion in an Orthotopic Mouse Model and in Epithelioid Pleural Mesothelioma Patients

Elliot L. Servais, Christos Colovos, Luis Rodríguez et al. · Clinical Cancer Research · 2012 · 209 citations · Full text

Veterinary Medicine, Cell Biology, Oncology +17

Mesothelin Overexpression Is a Marker of Tumor Aggressiveness and Is Associated with Reduced Recurrence-Free and Overall Survival in Early-Stage Lung Adenocarcinoma

Stefan S. Kachala, Adam J. Bograd, Jonathan Villena‐Vargas et al. · Clinical Cancer Research · 2013 · 190 citations · Full text

Medicine, Cancer Biology, Oncology +17

Palliation and Pleurodesis in Malignant Pleural Effusion: The Role for Tunneled Pleural Catheters

Kei Suzuki, Elliot L. Servais, Nabil P. Rizk et al. · Journal of Thoracic Oncology · 2011 · 106 citations · Full text

Medicine, Oncology, Surgery +14